IRIS
ANGELUCCI, ADRIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.822
EU - Europa 4.797
AS - Asia 4.553
SA - Sud America 438
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 18.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.713
SG - Singapore 1.866
CN - Cina 1.046
IE - Irlanda 1.007
RU - Federazione Russa 924
DE - Germania 614
TR - Turchia 510
IT - Italia 493
SE - Svezia 490
HK - Hong Kong 466
BR - Brasile 364
VN - Vietnam 354
GB - Regno Unito 339
UA - Ucraina 281
FR - Francia 256
FI - Finlandia 200
IN - India 73
CA - Canada 67
JP - Giappone 53
BD - Bangladesh 41
CZ - Repubblica Ceca 35
BE - Belgio 32
NL - Olanda 25
MX - Messico 23
AR - Argentina 20
ES - Italia 20
PL - Polonia 20
ZA - Sudafrica 19
IQ - Iraq 18
LT - Lituania 17
KR - Corea 16
EC - Ecuador 14
MA - Marocco 13
PK - Pakistan 12
UZ - Uzbekistan 12
SA - Arabia Saudita 10
TW - Taiwan 10
VE - Venezuela 10
CO - Colombia 9
EU - Europa 9
AT - Austria 7
ID - Indonesia 7
MY - Malesia 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
AU - Australia 5
AZ - Azerbaigian 5
PE - Perù 5
PY - Paraguay 5
UY - Uruguay 5
CH - Svizzera 4
CL - Cile 4
DZ - Algeria 4
IL - Israele 4
PA - Panama 4
PT - Portogallo 4
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
LB - Libano 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
RO - Romania 2
TL - Timor Orientale 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CU - Cuba 1
GE - Georgia 1
GI - Gibilterra 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
Totale 18.671
Salva come PNG Salva come JPEG
Città #
Dallas 1.219
Singapore 1.133
Jacksonville 1.103
Chandler 1.022
Dublin 1.004
San Jose 793
Ashburn 465
Hong Kong 458
Boardman 394
Santa Clara 390
Izmir 257
Council Bluffs 235
Nanjing 229
New York 204
San Mateo 200
The Dalles 200
Wilmington 165
Lawrence 145
Princeton 145
Moscow 144
Beijing 131
Ann Arbor 127
Lauterbourg 118
Bremen 117
Munich 117
Ho Chi Minh City 111
L'aquila 89
Los Angeles 80
Hanoi 76
Milan 66
Seattle 65
Nanchang 61
Woodbridge 61
Shenyang 53
Mountain View 49
Hefei 48
Helsinki 48
São Paulo 46
Tokyo 43
Des Moines 41
Hebei 39
Jiaxing 39
Rome 39
Verona 35
Brno 32
L’Aquila 32
Shanghai 32
Brussels 30
Frankfurt am Main 30
Tianjin 30
Strasbourg 28
Kunming 27
Brooklyn 26
Columbus 24
Orem 24
Da Nang 23
Zhengzhou 23
Changsha 21
Falls Church 21
Chicago 20
Philadelphia 20
Torre Del Greco 20
Jinan 19
Montreal 19
Ningbo 19
Toronto 19
Turku 19
Dearborn 18
San Francisco 18
Warsaw 18
Belo Horizonte 17
Chennai 17
Denver 17
London 17
Norwalk 17
Hangzhou 16
Houston 16
Stockholm 16
Guangzhou 15
Atlanta 14
Boston 14
Johannesburg 14
Manchester 13
Poplar 13
Pune 13
Falkenstein 12
Haiphong 12
Pescara 12
Taizhou 12
Tashkent 12
Teramo 12
Amsterdam 11
Phoenix 11
Dhaka 10
Lanzhou 10
Lappeenranta 10
Biên Hòa 9
Düsseldorf 9
Nuremberg 9
Rio de Janeiro 9
Totale 12.605
Salva come PNG Salva come JPEG
Nome #
Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma Treatment 448
Serum 25(OH)D seasonality in urologic patients from central Italy 218
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 208
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 195
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 161
Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disaster 158
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment 158
Obesity in the elderly - On the role of adipokines in prostate cancer progression 157
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 157
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer 157
Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion 155
Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesis. 150
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma 149
Introductory Immunology 147
In-vitro approaches to investigate the detrimental effect of light on dopaminergic neurons 145
Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer 145
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 144
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 144
Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures 140
Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism 139
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 139
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 138
Src family kinases as therapeutic targets in advanced solid tumors: What we have learned so far 138
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 137
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 137
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 135
Non-conventional role of haemoglobin beta in breast malignancy 135
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 135
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma 134
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 134
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 134
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 131
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 131
INIBITORI DI METALLOPROTEASI DI MATRICE: PROSPETTIVE TERAPEUTICHE. EOS - JOURNAL OF IMMUNOLOGY AND IMMUNOPHARMACOLOGY, VOL.XXI – 2001 – N.1: 22-27 130
NF-κB: A Druggable Target in Acute Myeloid Leukemia 129
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 129
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 128
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 128
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 127
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis 126
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 126
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 125
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 125
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 125
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 125
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 125
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 125
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 124
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 124
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 124
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 124
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells 124
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 123
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells 123
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 123
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 122
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 122
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 121
Plasma brain-derived neurotrophic factor in earthquake survivors with full and partial post-traumatic stress disorder 121
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 120
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 119
The importance of tumor stem cells in glioblastoma resistance to therapy 119
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 118
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 118
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 118
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-D] PYRIMIDINE AND PYRROLO [2,3-D] PYRIMIDINE AND USES THEREOF 118
Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant 117
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells 117
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 117
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering 117
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 116
Apoptosis or programmed cell death 116
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 116
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation 116
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 115
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 114
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 114
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 114
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models 114
Extracellular vesicles: New endogenous shuttles for mirnas in cancer diagnosis and therapy? 114
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones 113
Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors 113
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors 112
Fenomeni adattativi dopo terapia antiandrogenica nel tumore della prostata 112
Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer 111
Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs) 111
Targeting ERBB receptors to inhibit metastasis: old hopes and new certainties 109
Apoptosi e sistema immunitario: regolazione e patologie associate 109
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells 109
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 108
Possibile anti-apoptotic activity of carnitines on excitatory amino acid induced neurotoxicity 108
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 108
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 107
Therapeutic potential of Askina® Gel in regenerative medicine 107
A 3D Bioprinting Approach to Studying Retinal Müller Cells 106
Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines 106
Increased BDNF levels after a trauma A pilot study on clinical and non-clinical samples, exposed or non-exposed to an earthquake 106
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 105
Therapeutic potential of a biomatrix (Askina gel) in regenerative medicine 104
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 103
Totale 13.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 0 0 0 0 0 0 61
2021/2022980 63 88 183 66 43 23 15 52 48 33 82 284
2022/20233.005 198 157 57 314 346 321 3 214 1.238 19 90 48
2023/2024728 99 45 40 126 53 215 12 37 2 17 20 62
2024/20252.949 74 74 233 112 373 251 373 267 639 142 240 171
2025/20266.682 253 618 955 825 600 440 1.073 230 490 727 391 80
Totale 18.809